A biomarker-directed, multi-center phase II/III study of ctDNA molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer (BR.36). Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Anagnostou, Valsamo
  • Moore, Sara
  • Bradbury, Penelope Ann
  • Ho, Cheryl
  • Juergens, Rosalyn
  • Sacher, Adrian G
  • Genta, Sofia
  • Pitre, Lacey
  • Febbraro, Michela
  • Brahmer, Julie R
  • Avrutin, Egor
  • Gaudreau, Pierre-Olivier
  • Sausen, Mark
  • Upadhaya, Samik
  • Zhou, Alicia
  • Ding, Keyue
  • Dancey, Janet Ellen

publication date

  • June 2025